Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-23-000054

Options or other derivatives

  • Chief Executive Officer acquired 558,221 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smith Christopher M · Chief Executive Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-05-11 Grant or award : show line 1 in the form Stock Option (Right to Buy) +269,841 269,841 D
2023-05-11 Grant or award : show line 2 in the form Restricted Stock Unit +144,190 144,190 D
2023-05-11 Grant or award : show line 3 in the form Performance Stock Unit +144,190 144,190 D
Loading xslF345X04/wf-form4_168418480755854.xml…